You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

recurrent verrucous carcinoma of the larynx

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Squamous

Recruiting
  • Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
  • +50 more
  • transoral robotic surgery
  • quality of life assessment
  • Columbus, Ohio
    Ohio State University Medical Center
Oct 28, 2022

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With

Completed
Has Results
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +35 more
  • PI3K inhibitor BKM120
  • cetuximab
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Sep 14, 2021

Head Neck Cancer, Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous

Completed
Has Results
  • Head and Neck Cancer
  • +19 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of The University of Pennsylvania
Mar 6, 2020

Squamous Cell Carcinoma of the Oropharynx, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Oral Cavity

Active, not recruiting
Has Results
  • Squamous Cell Carcinoma of the Oropharynx
  • +7 more
  • Tampa, Florida
  • +2 more
Dec 30, 2022

Head Neck Cancer Trial in San Diego (Medpulser Electroporation with Bleomycin, Surgical Excision)

Terminated
  • Head Neck Cancer
  • Medpulser Electroporation with Bleomycin
  • Surgical Excision
  • San Diego, California
    Inovio Biomedical Corporation
Mar 2, 2022

Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell

Active, not recruiting
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +29 more
  • Cytology specimen
  • Laboratory biomarker analysis
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Aug 31, 2021

Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell

Terminated
Has Results
  • Stage III Squamous Cell Carcinoma of the Hypopharynx
  • +11 more
  • cetuximab
  • +3 more
  • Newark, New Jersey
    New Jersey Medical School
Apr 19, 2021

Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Squamous Cell Carcinoma of the Hypopharynx, Metastatic Squamous

Active, not recruiting
  • Metastatic Head and Neck Squamous Cell Carcinoma
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 27, 2022

Head Neck Cancer Trial in Nashville (biologic sample preservation procedure, medical chart review)

Recruiting
  • Head and Neck Cancer
  • biologic sample preservation procedure
  • medical chart review
  • Nashville, Tennessee
  • +3 more
Oct 28, 2022

Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell

Completed
Has Results
  • Stage IV Squamous Cell Carcinoma of the Hypopharynx
  • +3 more
  • Boston, Massachusetts
  • +1 more
Feb 11, 2021

Mucositis, Oral Complications, Recurrent Adenoid Cystic Carcinoma of the Oral Cavity Trial in United States (acetylcysteine, ,

Completed
Has Results
  • Mucositis
  • +82 more
  • Scottsdale, Arizona
  • +4 more
Apr 22, 2019

Leukoplakia, Oral Trial in Boston (Nivolumab)

Active, not recruiting
  • Leukoplakia, Oral
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Sep 19, 2022

Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell

Terminated
Has Results
  • Stage III Squamous Cell Carcinoma of the Hypopharynx
  • +11 more
  • erlotinib hydrochloride
  • +10 more
  • Cleveland, Ohio
    Case Medical Center, University Hospitals Seidman Cancer Center,
May 6, 2020

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Salivary Gland Squamous Cell Carcinoma, Stage 0

Completed
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +57 more
  • placebo
  • +3 more
  • Columbus, Ohio
    Ohio State University Medical Center
Feb 18, 2020

Squamous Cell Carcinoma of Oral Cavity, Pharynx Carcinoma, Larynx Carcinoma Trial in Gliwice (Chemotherapy

Recruiting
  • Squamous Cell Carcinoma of Oral Cavity
  • +3 more
  • Chemotherapy (carboplatin+paclitaxel) with concomitant low dose ionizing radiotherapy
  • Gliwice, Silesia, Poland
    The Maria Sklodowska-Curie National Research Institute of Oncolo
Aug 7, 2023

Head Neck Cancer, Mucositis Oral, Radiation Toxicity Trial in San Francisco (sargramostim, oral salt and soda mouthwash)

Completed
Has Results
  • Head and Neck Cancer
  • +3 more
  • sargramostim
  • oral salt and soda mouthwash
  • San Francisco, California
    University of California, San Francisco
Jul 9, 2021

Following Salvage Surgery for RESidual or reCurrent sqUamous

Not yet recruiting
  • Head and Neck Cancer
  • Molecular Analyses
  • (no location specified)
Mar 28, 2023

Recurrent Colon Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma Trial

Completed
  • Recurrent Colon Carcinoma
  • +41 more
  • Cetuximab
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Mar 12, 2020

Squamous Cell Carcinoma of Larynx Trial in São Paulo (carboplatin AUC of 6, paclitaxel 175 mg/m2, and pembrolizumab 200 mg, i.v.

Recruiting
  • Squamous Cell Carcinoma of Larynx
  • carboplatin AUC of 6, paclitaxel 175 mg/m2, and pembrolizumab 200 mg, i.v. on day 1, every 21 days for 3 cycles
  • +2 more
  • São Paulo, Brazil
    Beneficiencia Portuguesa de São Paulo/Hospital São José
Dec 22, 2022

Larynx Cancer, Hypopharyngeal Cancer Trial in Shanghai (procedure, radiation, drug)

Recruiting
  • Larynx Cancer
  • Hypopharyngeal Cancer
  • Surgery
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Sep 9, 2023

Sinonasal Cancer, Squamous NSCLC, Lung Cancer Trial run by the National Cancer Institute (NCI) (pembrolizumab, valemetostat)

Not yet recruiting
  • Sinonasal Cancer
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 5, 2023

Hepatocellular Carcinoma Trial in United States (AZD5851)

Not yet recruiting
  • Hepatocellular Carcinoma
  • AZD5851
  • Duarte, California
  • +9 more
Oct 12, 2023

Head and Neck Squamous Cell Carcinoma, PET/CT Trial (Neck dissection)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • PET/CT
  • Neck dissection
  • (no location specified)
Jan 31, 2023

Head-and-neck Cancer Trial in Denmark (Proton radiotherapy)

Active, not recruiting
  • Head-and-neck Cancer
  • Proton radiotherapy
  • Aalborg, Denmark
  • +6 more
Jun 15, 2022

Recurrent Head Neck Cancer, Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Carcinoma Trial in Saint

Not yet recruiting
  • Recurrent Head and Neck Cancer
  • +5 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 30, 2023